The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of asparaginase discontinuation on outcome in childhood ALL: A report from the Children’s Oncology Group (COG).
 
Sumit Gupta
No Relationships to Disclose
 
Cindy Wang
No Relationships to Disclose
 
Elizabeth A. Raetz
Research Funding - Pfizer (Inst)
 
Reuven J. Schore
Consulting or Advisory Role - Baxalta; Shire
Research Funding - Merck Sharp & Dohme (Inst); Millennium (Inst); Onyx (Inst); Pfizer (Inst)
 
Wanda L. Salzer
No Relationships to Disclose
 
Eric Larsen
No Relationships to Disclose
 
Kelly W. Maloney
No Relationships to Disclose
 
Leonard A. Mattano
Stock and Other Ownership Interests - Amgen; Amgen (I); Monsanto; Monsanto (I); Pfizer; Pfizer (I)
Consulting or Advisory Role - Melinta Therapeutics; Melinta Therapeutics (I); Mylan; Novartis; Pfizer
 
William L. Carroll
Other Relationship - Amgen
 
Naomi J. Winick
No Relationships to Disclose
 
Stephen Hunger
Stock and Other Ownership Interests - Amgen; Amgen (I); Merck (I); Pfizer (I)
Honoraria - Amgen
Consulting or Advisory Role - Novartis
 
Mignon L. Loh
No Relationships to Disclose
 
Meenakshi Devidas
Honoraria - PSI
Travel, Accommodations, Expenses - PSI